Meclonazepam - a new therapy for parasitic flatworm infection schistosomiasis
Medical research is never done. Praziquantel has been an effective treatment for schistosomiasis, a tropical disease caused by parasitic flatworms, since the 1980s, but there are now growing fears that drug resistance might be starting to emerge. Backup treatments are therefore needed, so researchers have turned to an old compound that might have untapped potential, called meclonazepam. They found it successfully killed the parasites (pictured, seven-week infection worms without treatment, left, and after exposure to meclonazepam, right). The team examined the impact the treatment had on the worms’ genetic activity and saw changes in the expression (switched on/up or off/down) of genes unique to flatworms. Importantly the impact of meclonazepam was the same on worms susceptible or resistant to the conventional treatment, suggesting it could be a powerful alternative therapy in the fight against schistosomiasis.
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.